Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study. Xie W, Li J, Du H, Xia J, et al. Arthritis Res Ther 2023;25:148.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xie W, Li J, Du H, Xia J, et al. Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study. Arthritis Res Ther 2023;25:148.
PMID: 37580807